SR 11302 is primarily utilized in research settings to study its effects on cellular processes, particularly in the context of cancer and inflammation. It functions as an inhibitor of AP-1 transcription factor activity, which plays a crucial role in regulating genes involved in cell proliferation, differentiation, and apoptosis. By blocking AP-1, SR 11302 helps researchers understand the molecular mechanisms underlying tumor growth and inflammatory responses. This compound is also used in experimental models to evaluate its potential therapeutic applications, such as reducing tumor progression or mitigating chronic inflammatory diseases. Its ability to modulate gene expression makes it a valuable tool in molecular biology and pharmacology studies.